Fresenius Medical Care AG

Fresenius Medical Care operates as a vertically integrated provider of dialysis services and related healthcare products for patients with renal disease. The company manages a network of outpatient dialysis clinics where it delivers treatment directly to patients, alongside ancillary services including clinical monitoring, laboratory diagnostics, and supply delivery. The company also provides dialysis services to hospitals treating hospitalized end-stage renal disease (ESRD) patients and those experiencing acute kidney failure.

The company's revenue streams are organized through two primary segments. The Care Delivery segment encompasses the operation of dialysis clinics and related patient services. The Care Enablement segment focuses on the manufacture and distribution of medical devices and pharmaceuticals, including hemodialysis machines, peritoneal dialysis equipment, dialysis solutions, concentrates, bloodlines, and renal medications. The company also markets products for acute cardiopulmonary and apheresis treatment, along with water treatment systems for clinical use.

Fresenius Medical Care operates internationally with significant presence in Germany and the United States. The company employs approximately 110,000 full-time staff across its operations. Distribution of products occurs through direct sales to dialysis clinics and hospitals, as well as through independent distributors and sales agents. The company was incorporated in 1996 and maintains headquarters in Bad Homburg, Germany, with listing on the New York Stock Exchange.